Kirsten Gruis
Overview
Kirsten Gruis received an average of $800K in total compensation, including $331K in salary, at DiaMedica Therapeutics between 2022 and 2023.
Source: SEC filings on April 4, 2024 and April 4, 2023.
Related executives
We found five more executives who work or worked at DiaMedica Therapeutics.
Rick Pauls
DiaMedica Therapeutics
Chief Executive Officer
Scott Kellen
DiaMedica Therapeutics
Chief Financial Officer
Julie Daves
DiaMedica Therapeutics
SVP, Clinical Development Operations
Harry Alcorn
DiaMedica Therapeutics
Senior Vice President of Clinical Operations
Todd Verdoorn
DiaMedica Therapeutics